NCT00052845 2016-07-01
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Alliance for Clinical Trials in Oncology
Phase 2 Completed
Clinical Trials
3 trialsNCT00078910 2013-06-24
Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00166426 2009-11-16
Exisulind Versus Placebo After Surgical Removal of the Prostate
Mayo Clinic
Phase 2 Completed